Skip to main content

U.S.-Japan Technology Linkages in Biotechnology Challenges for the 1990s (1992) / Chapter Skim
Currently Skimming:

4. PROSPECTS FOR THE FUTURE
Pages 45-50

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 45...
... In 1991 nearly $4 billion in equity capital was raised in the United States. This new financing provides U.S.
Read the entire page →
From page 46...
... Estimates of the biotechnology market in the United States, Japan, and Europe in the year 2000 vary considerably. According to an analysis by the North Carolina Biotechnology Center, the Japanese market will see sales of $30 billion in the year 2000, exceeding sales in the United States or Europe.
Read the entire page →
From page 47...
... _ ~ . // United States ~ ~ Europe // _ - ~ - Japan / f , _ ,=~A ,,"" =' i I 2000 innovation is occurring: cutting-edge technology being efficiently (in terms of both time and financing)
Read the entire page →
From page 48...
... linkages with small firms. As academic institutions around the world, and principally in the United States, look for corporate support for continued funding, Japanese companies are likely to become increasingly involved.
Read the entire page →
From page 49...
... Therefore, the trend will be for Japanese companies to build research facilities in the United States as a vehicle to develop and export technology and completed products to Japanese companies for worldwide commercialization. Since the worldwide pharmaceuticals industry is not dominated by Japanese companies, nonhealth care biotechnology (i.e., electronics, energy, chemicals)
Read the entire page →
From page 50...
... Should this change in the United States during the l990s, there will be more Japanese linkages as sources of capital, and, therefore, more strategic alignments. The overall conclusion drawn by the NRC working group is that current trends will continue but that there may be some new developments in Japan that bear careful analysis and response.
Read the entire page →

Key Terms

  • japanese companies
  • property protection
  • european companies
  • venture capital
  • regulatory interfaces

  • japanese market
  • strategic alliances
  • nonhealth care
  • companies involved
  • capital market

  • japanese linkages
  • own regulatory
  • earlier stages
  • biotechnology believe
  • capital investment

  • bring specific
  • alliances shortly
  • critical technology
  • worldwide commercialization
  • vary considerably

  • biotechnology world
  • strategic alignment
  • care technology
  • achieve parity
  • strategic linkages

  • industry growth
  • linkage partners
  • corporate partners
  • encouraging venture
  • increasingly pay


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.